Sinopharm Group Co. Ltd.

Informe acción DB:X2S

Capitalización de mercado: €7.9b

Sinopharm Group Propiedad

¿Quiénes son los principales accionistas, y ha habido compras o ventas con información privilegiada?


Operaciones recientes con información privilegiada

Transacciones recientes de empresas o particulares con información privilegiada de DB:X2S
FechaValorNombreEntidadCargoAccionesPrecio máximo
28 Oct 24Buy€12,761JP Morgan Asset ManagementCompany5,316€2.40
28 Oct 24Sell€6,013JP Morgan Asset ManagementCompany2,505€2.40
28 Oct 24Sell€2,130,450JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany887,540€2.40
25 Oct 24Buy€21,412,580JP Morgan Asset ManagementCompany9,115,844€2.35
25 Sep 24Buy€4,812,029JP Morgan Asset ManagementCompany2,286,132€2.10
24 Sep 24Sell€22,797,649FMR LLCCompany11,563,600€1.97
20 Sep 24Buy€20,787,474Lazard Asset Management LLCCompany10,551,655€1.97
17 Sep 24Buy€780,872FMR LLCCompany400,377€1.95
09 Sep 24Sell€6,469,215FMR LLCCompany3,308,800€1.96
30 Aug 24Sell€17,640,372Lazard Asset Management LLCCompany8,368,845€2.11
29 Aug 24Buy€5,041JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,400€2.10
29 Aug 24Buy€1,573,775JP Morgan Asset ManagementCompany749,225€2.10
29 Aug 24Sell€3,361JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany1,600€2.10
29 Aug 24Sell€1,098,445JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany522,935€2.10
28 Aug 24Buy€34,728JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,120€2.03
28 Aug 24Sell€3,956JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany1,950€2.03
28 Aug 24Sell€2,311,755JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,139,648€2.03
27 Aug 24Buy€6,177,513JP Morgan Asset ManagementCompany3,040,157€2.03
31 Jul 24Buy€18,495,176Lazard Asset Management LLCCompany8,516,475€2.17
30 Jul 24Buy€3,372,514JP Morgan Asset ManagementCompany1,593,179€2.12
19 Jul 24Sell€2,963,773JP Morgan Asset ManagementCompany1,337,657€2.22
18 Jul 24Buy€3,161,212JP Morgan Asset ManagementCompany1,399,723€2.26
02 Jul 24Sell€21,324,912Lazard Asset Management LLCCompany8,601,240€2.48
28 Jun 24Buy€877JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany354€2.48
28 Jun 24Sell€569,804JP Morgan Asset ManagementCompany229,904€2.48
28 Jun 24Sell€2,786JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany1,124€2.48
28 Jun 24Sell€239,453JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany96,614€2.48
27 Jun 24Buy€575,437JP Morgan Asset ManagementCompany233,733€2.46
04 Jun 24Sell€21,385,875BlackRock, Inc.Company8,561,564€2.50
31 May 24Buy€21,082,199Lazard Asset Management LLCCompany8,433,700€2.50
27 May 24Buy€4,516,302JP Morgan Asset ManagementCompany1,782,990€2.53
17 May 24Sell€3,629,409JP Morgan Asset ManagementCompany1,401,913€2.59
16 May 24Buy€2,115,312JP Morgan Asset ManagementCompany804,532€2.63
02 May 24Buy€368,237JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany158,476€2.32
02 May 24Sell€2,238,567JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany963,399€2.32
30 Apr 24Buy€2,991,404JP Morgan Asset ManagementCompany1,250,018€2.39
02 Apr 24Buy€2,424,923FMR LLCCompany997,600€2.43
05 Feb 24Buy€5,524,528JP Morgan Asset ManagementCompany2,261,865€2.44

Volumen de trading con información privilegiada

Compra de información privilegiada: Datos insuficientes para determinar si personas con información privilegiada han comprado más acciones de las que han vendido en los últimos 3 meses.


Desglose de propiedad

¿Cuál es la estructura de propiedad de X2S?
Tipo de propietarioNúmero de accionesPorcentaje de participación
Personas con información privilegiada159.0090,0051 %
Público general519.350.85216,6 %
Instituciones822.300.87926,4 %
Empresas privadas1.778.845.45157 %

Dilución de acciones: Los accionistas no se han visto significativamente diluidos en el último año.


Principales accionistas

Los 25 principales accionistas poseen un 79.24% de la empresa
PropiedadNombreAccionesValor actualVariación %% Cartera
57 %
China National Pharmaceutical Group Corporation
1.778.845.451€4.5b0 %Sin datos
4,82 %
FMR LLC
150.404.494€380.0m-6,91 %0,02 %
3,68 %
Lazard Asset Management LLC
114.698.209€289.8m5,04 %0,26 %
2,57 %
JP Morgan Asset Management
80.336.772€203.0m-3,35 %0,02 %
1,89 %
BlackRock, Inc.
59.082.462€149.3m-22,1 %Sin datos
1,68 %
The Vanguard Group, Inc.
52.380.677€132.3m0,13 %Sin datos
1,15 %
Dimensional Fund Advisors LP
35.793.435€90.4m0,18 %0,01 %
0,85 %
State Street Global Advisors, Inc.
26.432.613€66.8m0,38 %Sin datos
0,69 %
Bosera Asset Management Co., Ltd.
21.446.800€54.2m0 %0,24 %
0,64 %
Value Partners Hong Kong Limited
19.820.000€50.1m0 %1,91 %
0,53 %
Norges Bank Investment Management
16.398.891€41.4m0 %Sin datos
0,46 %
Nordea Investment Management, AB
14.303.381€36.1m0 %0,02 %
0,45 %
Swedbank Robur Fonder AB
13.986.463€35.3m0 %0,02 %
0,43 %
Wasatch Advisors LP
13.330.400€33.7m0 %0,11 %
0,36 %
Geode Capital Management, LLC
11.314.841€28.6m2,22 %Sin datos
0,3 %
Charles Schwab Investment Management, Inc.
9.307.585€23.5m0,56 %Sin datos
0,27 %
JPMorgan Chase & Co, Brokerage and Securities Investments
8.390.482€21.2m10,9 %0,01 %
0,25 %
China Asset Management Co. Ltd.
7.803.716€19.7m-0,05 %0,02 %
0,24 %
UBS Asset Management AG
7.440.929€18.8m21,4 %Sin datos
0,23 %
Andra AP-fonden
7.054.800€17.8m0 %0,1 %
0,18 %
Bin Yuan Capital Limited
5.560.753€14.0m0 %2,71 %
0,18 %
PineBridge Investments LLC
5.470.400€13.8m0 %0,07 %
0,15 %
Hang Seng Investment Management Limited
4.700.410€11.9m0 %0,12 %
0,14 %
Guotai Asset Management Company Limited
4.264.388€10.8m0 %0,04 %
0,14 %
Amundi Asset Management SAS
4.244.888€10.7m2,21 %Sin datos